SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-072873
Filing Date
2020-03-13
Accepted
2020-03-13 16:05:33
Documents
6
Period of Report
2020-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d903203d8k.htm 8-K 30304
2 EX-99.1 d903203dex991.htm EX-99.1 43724
3 EX-99.2 d903203dex992.htm EX-99.2 10563
4 GRAPHIC g903203g0312174844057.jpg GRAPHIC 5783
5 GRAPHIC g903203g0312174844213.jpg GRAPHIC 3916
6 GRAPHIC g903203g0313033405813.jpg GRAPHIC 3525
  Complete submission text file 0001193125-20-072873.txt   104685
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 20712652
SIC: 2834 Pharmaceutical Preparations